Siplizumab for Sickle Cell Disease Transplant
Clinical trial NCT06078696 · TERMINATED
Trial details
- NCT number
- NCT06078696
- Sponsor
- Columbia University
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-28
- Primary completion
- 2024-12-11
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.